Get started
Author

Maria Fernanda Tosin

Observed names: Fernanda Tosin, M F Tosin, María Fernanda Tosin
ORCID: 0009-0003-8153-9728
Observed ORCID: 0009-0003-8153-9728
OpenAlex ID: A5005831869
Long-Term Follow-Up in Patients With Chronic Myeloid Leukemia Treated With Ponatinib in a Real-World Cohort: Safety and Efficacy Analysis
2023 · María José Mela Osorio, Beatriz Moiraghi, et al. · Clinical Lymphoma Myeloma & Leukemia · 9
Immune checkpoints PD1/PDL1, TIM3/GAL9 and key immune mediators landscape reveal differential expression dynamics on imatinib response in chronic myeloid leukemia
2024 · María Jazmín Toloza, Marco Lincango, et al. · Annals of Hematology · 4
Challenges of Dengue in Hematological Disease Patients: Descriptive Analysis From the DANGO Registry During the 2023–2024 Outbreak in Argentina
2026 · Gustavo Adolfo Méndez, Carla Niveyro, et al. · Transplant Infectious Disease · 2
Genetic variability profiling of the p53 signaling pathway in chronic lymphocytic leukemia. Individual and combined analysis of TP53, MDM2 and NQO1 gene variants
2024 · María Belén Fontecha, María Del Rosario Anadón, et al. · Annals of Hematology · 2
Long-Term Follow-up of the AST Trial of Treatment-Free Remission in Chronic Myeloid Leukemia Patients
2023 · Ricardo K Tannuri, Beatriz Moiraghi, et al. · Blood · 1
Toxicity and Outcomes of Ibrutinib in Chronic Lymphatic Leukemia-Real-World Results from the Study of 215 Patients in Argentina
2023 · Horacio Fernández Grecco, Pablo Valdemoros, et al. · International Journal of Clinical and Experimental Medical Sciences · 1
PDF
Crisis blástica súbita: tan infrecuente como imprevisible
2026 · Marina Santas, Maria Fernanda Tosin · Revista Hematología
PDF
Identification of Predictive Biomarkers Based on Cytokine Profiles for Molecular Relapse After Treatment-Free Remission in Chronic Myeloid Leukemia Patients
2026 · Bianca Vasconcelos Cordoba, Carolina Pavlovsky, et al. · Cells
PDF
P-2184. Challenges of dengue in haematological malignancy patients: Analysis from the DANGO registry during the 2023-2024 outbreak in Argentina
2026 · Jon Salmanton-Garcia, Carla Niveyro, et al. · Open Forum Infectious Diseases
PDF
Integrating cytokine profiles with clinical and molecular biomarkers to predict molecular relapse after TKI discontinuation in CML patients
2025 · Carolina Pavlovsky, Bianca Vasconcelos Cordoba, et al. · Blood
Assessing Molecular Relapse-Free Survival in Latin American Chronic Myeloid Leukemia Patients Undergoing TKI Dose Reduction
2024 · Melina Gisel Luft, Ricardo Khalil Tannuri, et al. · Blood
Perfil de seguridad de la angioplastia pulmonar con balón bajo anticoagulación con antagonistas de vitamina K
2020 · Alejandra Martí, Noelia Saaby, et al.
AML-392: Experience in AML Treatment in a Public Tertiary Facility
2020 · Alicia Navickas, Soledad Cruset, et al. · Clinical Lymphoma Myeloma & Leukemia
ABCL-255: Prognostic Significance of PET CT in Relapsed/Refractory Diffuse Large B Cell Non-Hodgkin Lymphoma Before Transplantation of Autologous Hematopoietic Progenitors: Experience of a Public Hospital
2020 · Lautaro Marcelo Sardu, Fernanda Tosin, et al. · Clinical Lymphoma Myeloma & Leukemia
Prognostic Impact of PET TC in Relapsed Refractory Hodgkin Lymphoma Previous to Autologous Stem Cell Transplantation - Institutional Experience in a Public University Hospital
2019 · Lautaro Sardu, Maria Fernanda Tosin, et al. · Clinical Lymphoma Myeloma & Leukemia
Works count: 16
Citation count: 19
H-index: 2
I10-index:
Year
Topic
Type